Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:15:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:13:01.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:06.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-13T17:36:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:02:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has added a facility name and location, along with new content related to skin and connective tissue diseases and specific drugs like ostarine and pembrolizumab. However, it has removed several location-related terms and resources related to breast cancer and genetic diseases.
    Difference
    2%
    Check dated 2025-08-30T11:51:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.